Specific mode of interaction between components of model pulmonary surfactants using computer simulations.
Atomistic molecular dynamics simulations and structural bioinformatics tools enable the identification of the exact mode of interaction between model pulmonary surfactant components. Two nanosecond long simulations of the N-terminal region of human surfactant protein-B (SP-B(1-25)) in dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylglycerol (DPPG) monolayers of different lipid surface densities reveal the preferential affinity of SP-B(1-25) for anionic phospholipids. In particular, arginine 12 and lysine 24 interact strongly and with high specificity with the phosphate group of the DPPG lipids, stabilizing the position, the orientation, and the secondary structure of the peptide in the monolayer. The peptide lies at an oblique angle to the interfacial plane, ranging between 47 degrees and 62 degrees, increasing with decreasing lipid surface density. In DPPC monolayers the interaction is largely determined by hydrophobic interactions. The non-specific nature of DPPC-SP-B(1-25) interactions allows for significant flexibility in the topology of the peptide in the lipid matrix. Bioinformatics tools are employed to generalize the simulation results to the sequences of SP-B(1-25) in other organisms. The importance of specific residues, and the role of the largely helical and amphiphilic nature of the peptide in the functionality of SP-B(1-25) are established. The synergy of classical mechanics tools with bioinformatics methods greatly enhances the molecular-level interpretation of pulmonary surfactant action and facilitates the development of design rules for synthetic surfactant analogues.
Kaznessis
Yiannis N
YN
Department of Chemical Engineering, University of Michigan, 48109-2136, Ann Arbor, MI, USA. yiannis@cems.umn.edu
Kim
Sangtae
S
Larson
Ronald G
RG
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000737:chemistry; D019295:Computational Biology; D003198:Computer Simulation; D017124:Conserved Sequence; D006801:Humans; D008051:Lipid Bilayers; D050356:Lipid Metabolism; D008055:Lipids / Q000737:chemistry; D008567:Membranes, Artificial; D008958:Models, Molecular; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism; D010715:Phosphatidylglycerols / Q000737:chemistry; D011510:Proteolipids / Q000737:chemistry*; D011663:Pulmonary Surfactants / Q000737:chemistry*; D013499:Surface Properties; D013696:Temperature
D008051:Lipid Bilayers; D008055:Lipids; D008567:Membranes, Artificial; D010446:Peptide Fragments; D010715:Phosphatidylglycerols; D011510:Proteolipids; D011663:Pulmonary Surfactants; D015060:1,2-Dipalmitoylphosphatidylcholine; C030345:1,2-dipalmitoylphosphatidylglycerol